Ireland· IE-PA-EU/1/07/428/001

Abraxane 5 mg/ml powder for dispersion for infusion

A paclitaxel product containing paclitaxel, registered in Ireland by Bristol-Myers Squibb Pharma EEIG. The same ATC class is registered in 16 of our 19 countries.

ATC L01CD01

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about paclitaxelAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Paclitaxel is registered in 16 of 19 countries.

Countries holding a registration under ATC L01CD01 (paclitaxel), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
9 of them publish a price we can compare per daily dose

Search paclitaxel products by name

Paclitaxel · ATC L01CD01

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of paclitaxel costs, country by country.

Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.61 in Czechia to $19.82 in Switzerland — a ×32 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Paclitaxel · price per daily dose (15 mg)

USD · FX 28 Sept 2026

CH Switzerland$19.82
CZ Czechia$0.61

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Paclitaxel
Manufacturer: Bristol-Myers Squibb Pharma EEIG
Country: Ireland (IE)
ATC code: L01CD01
ATC class: Paclitaxel
Defined daily dose: 15 mg, P
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
EU/1/07/428/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

651 interactions on record for paclitaxel.

Graded by severity as the source publishes them — 41 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check paclitaxel against other medicines How interaction checks work

Paclitaxel · interactions on record

651 records

41 severe
302 moderate
17 minor
291 info

Most severe, free to view

SaquinavirJ05AE01severe
IndinavirJ05AE02severe
RitonavirJ05AE03severe
NelfinavirJ05AE04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Paclitaxel in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paclitaxel products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Apacross, Bugvi
Belgium · Apacross, Bugvi
Bulgaria · Алсикроса, Паклитаксел Акорд
Cyprus · Paclitaxel Accord, Paclitaxel Hospira
Czechia · Alsicrosa, Paclitaxel Ebewe
Germany · Apacross, Axitaxel
Denmark · Apacross, Bugvi
Estonia · Paclitaxel Accord, Paclitaxel Ebewe
Spain · Apacross, Bugvi
Finland · Apacross, Pacligen
France · Bugvi, Paclitaxel Ahcl
United Kingdom (Northern Ireland) · Apacross, Paclitaxel
Greece · Biotaxel, Paclitaxel Hospira
Croatia · Abutrax, Alsicrosa
Hungary · Bugvi, Paclitaxel Accord
Iceland · Abraxane, Apexelsin
Italy · Abutrax, Apacross
Liechtenstein · Abraxane, Apexelsin
Lithuania · Paclitaxel Accord, Paclitaxel Ebewe
Luxembourg · Bugvi, Paclitaxel Accord Healthcare
Latvia · Paclitaxel Accord, Paclitaxel Kabi
Malta · Paclitaxel Accord Healthcare, Paclitaxel Hospira
Netherlands · Abutrax, Apacross
Norway · Abraxane, Apacross
Poland · Paclitaxel Ebewe, Paclitaxel Kabi
Portugal · Apacross, Paclitaxel Accord
Romania · Bugvi, Paclitaxel Accord
Sweden · Apacross, Bugvi
Slovenia · Alsicrosa, Paclitaxin
Slovakia · Paclitaxel Accord, Paclitaxel Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/29e8b4f7-e4ad-457c-9621-f058433b9b63
GET /v1/drugs/29e8b4f7-e4ad-457c-9621-f058433b9b63?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for concentrate for dispersion for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01CD",
    "L01CD01"
  ],
  "strength": null,
  "pa_number": "EU/1/07/428/001",
  "substances": [
    "Paclitaxel"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "11/01/2008",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about paclitaxel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console